28th fda catalyst
Commento
Fundamentals are very poor, last submission to FDA failed making the stakes very high for long term investors, could start to push bearish under the support level.
Commento
Either that or big corps will interfere putting funds in for a bullish look grabbing the attention of traders to push upwards.
Beyond Technical AnalysiscatalystfdafibTechnical IndicatorsPHARMATrend Analysis
pat845

Declinazione di responsabilità